One question that comes to mind is when did they apply for Regulatory Approval in these countries. If it was at the trials inception I would regard it as "well done" but would find the approval a neutral event.
Anavex is already "tight" in Canada with thr highly regarded McGill University. Certainly McGill connections will be involved in rolling out the clinical trial.